High Dose Influenza Vaccine in Nursing Home - Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

2,957

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2016

Conditions
Influenza
Interventions
BIOLOGICAL

HD Fluzone Vaccine

Nursing home residents over 65 years are allocated to receive high dose trivalent vaccine. Residents under 65 years are provided standard dose trivalent vaccine (TIV).

BIOLOGICAL

SD Fluzone Vaccine

Nursing home residents are allocated to receive standard trivalent vaccine (TIV).

Trial Locations (2)

23510

Insight Therapeutics, Norfolk

02903

Brown Univeristy, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Brown University

OTHER

lead

Insight Therapeutics, LLC

OTHER